StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Vascular by Quarter

Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — Worldwide Net Sales ($M) ($M)

QuarterlyAnnual

Stryker Vascular: $566M in Q3 2026, up 7.8% from a year earlier. That is the highest of the 24 quarters on record here.

Latest, Q3 2026
566
Period ended Sep 30, 2026
Change on a year earlier
+7.8%
525 in Q3 2025
History
24 quarters
Since Q4 2020
Sources
20
Documents cited below

Where the Q3 2026 figure comes from

Renamed from Neurovascular to Vascular in 2025 following the February 2025 acquisition of Inari Medical (Peripheral Vascular).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedVascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — Worldwide Net Sales ($M) ($M)Year on yearSource
Q3 2026Sep 30, 2026566+7.8%0000310764-26-000059|sykex991earningsq32026.htm ↗
Q2 2026Jun 30, 2026496-0.4%0000310764-26-000048|sykex991earningsq22026.htm ↗
Q1 2026Mar 31, 2026517+27.3%0000310764-26-000025|sykex991earningsq12026.htm ↗
Q4 2025Dec 31, 2025539+58.1%0000310764-26-000006|sykex991earningsq42025.htm ↗
Q3 2025Sep 30, 2025525+59.6%0000310764-25-000126|sykex991earningsq32025.htm ↗
Q2 2025Jun 30, 2025498+52.3%0000310764-25-000103|sykex991earningsq22025.htm ↗
Q1 2025Mar 31, 2025406+31.0%0000310764-25-000072|sykex991earningsq12025.htm ↗
Q4 2024Dec 31, 2024341+6.6%0000310764-25-000005|sykex991earningsq42024.htm ↗
Q3 2024Sep 30, 2024329+5.8%0000310764-24-000113|sykex991earningsq32024.htm ↗
Q2 2024Jun 30, 2024327+5.1%0000310764-24-000095|sykex991earningsq22024.htm ↗
Q1 2024Mar 31, 2024310+9.2%0000310764-24-000062|sykex991earningsq12024.htm ↗
Q4 2023Dec 31, 2023320+7.0%0000310764-24-000005|sykex991earningsq42023.htm ↗
Q3 2023Sep 30, 2023311+5.8%0000310764-23-000114|sykex991earningsq32023.htm ↗
Q2 2023Jun 30, 2023311+1.6%0000310764-23-000104|sykex991earningsq22023.htm ↗
Q1 2023Mar 31, 2023284-5.6%0000310764-23-000065|sykex991earningsq12023.htm ↗
Q4 2022Dec 31, 2022299-1.3%0000310764-23-000005|sykex991earningsq42022.htm ↗

Breakdown

What makes up vascular

Cite this data

StockData. (2026). Stryker Vascular ($M), quarterly Q4 2020–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-vasc-ww-rev

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.